These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 32584042)

  • 1. Nanomedicine for Acute Brain Injuries: Insight from Decades of Cancer Nanomedicine.
    Kandell RM; Waggoner LE; Kwon EJ
    Mol Pharm; 2021 Feb; 18(2):522-538. PubMed ID: 32584042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Nanomedicines for Polyglutamine-Based Neurodegenerative Diseases.
    Lee LKC; Leong LI; Liu Y; Luo M; Chan HYE; Choi CHJ
    Mol Pharm; 2021 Feb; 18(2):610-626. PubMed ID: 32584043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic Analysis of Peptide-Modified Nanoparticles with Engineered Physicochemical Properties in a Mouse Model of Traumatic Brain Injury.
    Waggoner LE; Madias MI; Hurtado AA; Kwon EJ
    AAPS J; 2021 Aug; 23(5):100. PubMed ID: 34401968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in nanomedicine development for traumatic brain injury.
    Ling Y; Ramalingam M; Lv X; Zeng Y; Qiu Y; Si Y; Pedraz JL; Kim HW; Hu J
    Tissue Cell; 2023 Jun; 82():102087. PubMed ID: 37060747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological rationale for the design of polymeric anti-cancer nanomedicines.
    Zhou Y; Kopeček J
    J Drug Target; 2013 Jan; 21(1):1-26. PubMed ID: 23009337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyanine Nanocage Activated by Near-IR Light for the Targeted Delivery of Cyclosporine A to Traumatic Brain Injury Sites.
    Black CE; Zhou E; DeAngelo C; Asante I; Yang R; Petasis NA; Louie SG; Humayun M
    Mol Pharm; 2020 Dec; 17(12):4499-4509. PubMed ID: 32813533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats.
    Sun D; Xue A; Zhang B; Lou H; Shi H; Zhang X
    J Pharm Pharmacol; 2015 Dec; 67(12):1650-62. PubMed ID: 26407669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine based nanoparticles for neurological disorders.
    Sriramoju B; Kanwar RK; Kanwar JR
    Curr Med Chem; 2014; 21(36):4154-68. PubMed ID: 25039778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.
    Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM
    Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury.
    Khalin I; Alyautdin R; Wong TW; Gnanou J; Kocherga G; Kreuter J
    Drug Deliv; 2016 Nov; 23(9):3520-3528. PubMed ID: 27278330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nootropic nanocomplex with enhanced blood-brain barrier permeability for treatment of traumatic brain injury-associated neurodegeneration.
    Park J; Choi E; Shin S; Lim S; Kim D; Baek S; Lee KP; Lee JJ; Lee BH; Kim B; Jeong K; Baik JH; Kim YK; Kim S
    J Control Release; 2018 Aug; 284():152-159. PubMed ID: 29913220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in nanomedicines: a promising therapeutic strategy for ischemic cerebral stroke treatment.
    Li J; Xie F; Ma X
    Nanomedicine (Lond); 2024 Apr; 19(9):811-835. PubMed ID: 38445614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
    Du JZ; Li HJ; Wang J
    Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ
    Drug Res (Stuttg); 2018 Oct; 68(10):584-595. PubMed ID: 29669380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Would antioxidant-loaded nanoparticles present an effective treatment for ischemic stroke?
    Poellmann MJ; Bu J; Hong S
    Nanomedicine (Lond); 2018 Sep; 13(18):2327-2340. PubMed ID: 30284494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microdialysis Monitoring in Clinical Traumatic Brain Injury and Its Role in Neuroprotective Drug Development.
    Thelin EP; Carpenter KL; Hutchinson PJ; Helmy A
    AAPS J; 2017 Mar; 19(2):367-376. PubMed ID: 28070712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 2-deoxy glucose surfaced mixed layer dendrimer: a smart neuron targeted systemic drug delivery system for brain diseases.
    Dhull A; Zhang Z; Sharma R; Dar AI; Rani A; Wei J; Gopalakrishnan S; Ghannam A; Hahn V; Pulukuri AJ; Tasevski S; Moughni S; Wu BJ; Sharma A
    Theranostics; 2024; 14(8):3221-3245. PubMed ID: 38855177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upconversion Nanoparticle-Based Strategy for Crossing the Blood-Brain Barrier to Treat the Central Nervous System Disease.
    Fu L; Chung R; Shi B
    Methods Mol Biol; 2019; 2054():263-282. PubMed ID: 31482461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.